BioNTech
Dominic Seiferling is an experienced professional in R&D program management and clinical research within the biotechnology and life sciences sectors. Currently serving as Associate Director of R&D Program Management at BioNTech SE since September 2022, Dominic leads global programs for TCR engineered T cell therapies. Prior to BioNTech, Dominic held the position of Clinical Research & Development Manager at Miltenyi Biomedicine, where the focus was on CAR-T cell therapy for hematological malignancies. Additional roles include Clinical Project Manager in cell and gene therapy and Project Manager at Projektträger Jülich, managing biomedical R&D projects and ensuring project milestones are met. Dominic's academic background includes a PhD in Genetics from the University of Cologne, supported by an M.Sc. in Biological Sciences and a B.Sc. in Biology.
This person is not in any teams
This person is not in any offices
BioNTech
32 followers
BioNTech was founded in 2008 on the understanding that every cancer patient’s treatment should be individualized. Their vision is to provide patient-specific immunotherapies worldwide.